Gilead’s HIV Franchise Powers Earnings Beat. The Rest Is a Work in Progress.

Gilead Sciences posts higher-than-expected sales as blockbuster HIV drug Biktarvy continues to drive its top line.

Rivian Earnings Show There Is Still Life in the EV Market

Rivian reported a gross profit of $176 million from sales of $2.2 billion. Wall Street was looking for a gross profit of $39 ...

Pinterest Stock Sinks as Signs Point to Slowing Revenue Growth

Pinterest missed expectations and guided to lower-than-expected revenue for the fourth quarter, sending its shares sharply ...

Boeing’s Earnings Were Great—for GE Aerospace

Gilead Sciences posts higher-than-expected sales as blockbuster HIV drug Biktarvy continues to drive its top line. ADT is now ...

The FTC Lawsuit Could Burn Toast’s Image More Than Its Stock Price

A new lawsuit against restaurant software and payment platform Toast TOST -1.36% accuses it of everything from unauthorized ...

U.S. Indexes Closed Down Thursday; ServiceNow Took Biggest Hit

U.S. stock indexes decreased Thursday as the NASDAQ Composite Index declined 1.38%. Meanwhile, the S&P 500 Index fell 0.30%, and the Dow fell 0.25%. Marvell Stock Slides. Why the Market Hates Idea of ...